IBB
HealthcareiShares Biotechnology ETF
iShares · Tracks NYSE Biotechnology Index · Inception Feb 5, 2001
Expense ratio
0.44%
44.0 bps
Net assets
$7.95B
TTM yield
0.23%
Last price
$167.91
as of May 20, 2026
Composite score
74 / 100
Cost 56
Based on a 0.44% expense ratio.
Liquidity 96
Based on $7.95B in net assets.
Concentration N/A
No holdings data available — N-PORT not filed or fund is not a 1940-Act registrant.
Tax efficiency 85
Healthcare base · ETF wrapper · 0.23% TTM yield.
Tracking quality N/A
Planned for a future methodology version. Not yet computed.
Scores reflect available inputs only. The composite is a weighted average over present sub-scores; weights renormalize when components are unavailable. See methodology for formulas (methodology v0.3.0).
Top holdings
No holdings data available for this fund.
Compare IBB with another fund
Or skim the closest-overlap funds below.